Articles On Invion (ASX:IVX)

Title Source Codes Date
Crucible: Dr Boreham’s A-To-Z of 2024 biotech

From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose...

Stockhead IVX 1 week ago
Aldoro goes nuts after niobium hits in Namibia

This week’s Bulls N’ Bears Runner of the Week is … Aldoro Resources. The Namibian explorer stacked on 201% after jagging niobium in trenching samples, while Macro Metals, Invion and Petratherm also ran hard.

The West IVX 2 weeks ago
ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

Stockhead IVX 3 weeks ago
Closing Bell: ASX gallops as healthcare sector jumps, led by Invion

ASX hits record high, driven by consumer stocks Zip co-founder steps down, Collins Foods drops Invion doubles after commencing phase I/II trial    The ASX hit a new record on Tuesday, marking its third all-time high in just a week.  At th...

Stockhead IVX 3 weeks ago
This small-cap ASX healthcare stock just exploded 131%! Here's why

Investors in ASX small-cap stock Invion Ltd (ASX: IVX) could have doubled their money today. All in a few hours' time. Shares in the ASX healthcare company closed yesterday trading for 18 cents. In earlier trade, shares were trading for 41....

Motley Fool IVX 3 weeks ago
Health Check: Let there be light (therapy). Invion up 160pc on skin cancer trial news

Invion enrols its first patient in its Queensland skin cancer study Inoviq says it has the clinical proof to commercialise its early-stage ovarian cancer detection test Are we on the cusp of Trump-driven US healthcare M&A fiesta?   I...

Stockhead IVX 3 weeks ago
Invion commences dosing in INV043 trial to treat non-melanoma skin cancer

Clinical-stage life sciences company Invion (ASX: IVX) has dosed the first patient in its Phase I/II non-melanoma skin cancer (NMSC) trial using active pharmaceutical ingredient and lead candidate INV043. The trial will aim to evaluate the...

SmallCaps IVX 3 weeks ago
Invion (ASX:IVX) – Webinar Presentation

  Thian Chew – Executive Chair and CEO – Invion Limited (ASX:IVX) is a clinical-stage life-science company that is leading the global research and development of the Photosoft technology for the treatment of a range of cancers, atherosclero...

ShareCafe IVX 3 weeks ago
Closing Bell: ASX hits all-time high as tech stocks lead broad rally

ASX hits record high with tech stocks leading TechnologyOne shares soar after strong earnings results Gold stocks rally as bullion rises above US$2600   The ASX surged to a new record on Monday, with technology and the other 10 sectors dr...

Stockhead IVX 1 month ago
Closing Bell: ASX ends Friday in style; NoviqTech explodes 180pc

ASX rises, but MinRes drops over transparency issues Fed boss Powell’s cautious rate cut stance cools market optimism NoviqTech shares surge after securing blockchain funding   The ASX rose by 0.74% on Friday, with 10 out of 11 sectors fi...

Stockhead IVX 1 month ago
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Stockhead IVX 1 month ago
ASX October Winners: The 50 best stocks in weaker month for markets

The S&P/ASX 200 fell 1.3% in October with small cap companies outperforming S&P Dow Jones Indices said financials led the gains in October and is up 30% YTD Ovanti rose 525% in October after appointment of former Zip US CFO Simon K...

Stockhead IVX 1 month ago
Closing Bell: Macquarie drags down bank stocks; Ironbark Zinc soars as Zelenski takes the chair

ASX opens November lower, led by financial sector sell-off Macquarie Group fell after profit decline Ironbark Zinc jumps 75% on new leadership   The ASX kicked off November with a thud, sliding about 0.5%. This  follows a tough session o...

Stockhead IVX 1 month ago
Closing Bell: ASX dips as AGL stalls; Talga skyrockets after Sweden approves graphite mine

  ASX slips  amid earnings updates and company meetings AGL drops over 6pc after downgrade, while Origin Energy rises Talga surges after Sweden approves graphite mine   The ASX slipped by 0.22% after being dragged by a flurry of company...

Stockhead IVX 1 month ago
Closing Bell: ASX slumps as Woolies fires warning; graphite stock GCM’s shares triple on new deal

  ASX slumps heavily after inflation data Australian inflation drops to 2.8pc, lower than expected Mining stocks rise while supermarket stocks struggle   The ASX trimmed its earlier gains following better-than-expected inflation figures....

Stockhead IVX 1 month ago
Top 10 at 11: Excellent MREC and a $115m EU grant are today’s news

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 2 months ago
Closing Bell: WiseTech drags again; 29Metals sinks 20pc on copper output

ASX edges slightly up by 0.12pc as traders rethink rate cuts Consumer staples shine while gold miners gain amid global tensions 29Metals plunges after cash reserve drop and production decline   The ASX ticked up higher by 0.1% on Wednesd...

Stockhead IVX 2 months ago
Closing Bell: ASX dips with MinRes and Viva tumbling; but Prodigy Gold hits jackpot

  The ASX fell on new expectations for rate cuts All 11 ASX sectors fell, with real estate and healthcare hit hardest MinRes and Viva Energy dropped, Prodigy Gold rose 50pc   The ASX slid by 1.66% from near record highs in a broad sell-o...

Stockhead IVX 2 months ago
Top 10 at 11: A real mixed bag to kick off the winner’s list for today

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 2 months ago
Closing Bell: ASX hits record, Nanoveu doubles on AI news, Tyro drops 10pc on new debit card proposal

  ASX 200 hits record highs fuelled by Wall Street rally Tech and iron ore stocks lead gains Tyro sinks after government proposes new rules on debit surcharge   The ASX 200 index hit record highs on Tuesday after rising by 0.9%, eclipsin...

Stockhead IVX 2 months ago
ASX Market Update: Tech and Resource Stocks Surge While Energy Faces Pressure

Highlights ASX 200 hits new record as InfoTech and Telcos lead early trading. Crude oil weakness impacts Woodside and Santos. Small-cap stocks Nanoveu and African Gold post strong gains. The ASX 200 opened on a high note today, bu...

Kalkine Media IVX 2 months ago
Closing Bell: Investors left high and dry after China disappoints; Iron ore, oil stocks swing to losses

ASX fell as mining stocks dropped on China’s lack of stimulus Brent oil dipped below US$80 Big lithium stocks fall, but smaller players keep gaining after Rio Tinto’s Arcadium takeover talks   The ASX closed lower by 0.35% in a volatile...

Stockhead IVX 2 months ago
Top 10 at 11: Nervous wait ahead of China news; but oil stocks, Panther Metals race out the blocks

Good morning, and welcome to Stockhead’s Top 10 at somewhere near 11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 2 months ago
Closing Bell: Arcadium soars 47pc as Rio makes move; retailers beg RBA to cut rates before Christmas

ASX rises as banking and tech sectors lead gains Arcadium Lithium surges on potential acquisition by Rio Tinto Retail groups urge Reserve Bank to cut rates ahead of holiday sales   The ASX200 index rose by 0.7% on Monday though investors...

Stockhead IVX 2 months ago
September
Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

Stockhead IVX 2 months ago
Closing Bell: Investors rush to mining stocks after China news; while Star crashes 40pc to new low

  ASX rises modestly with mining stocks leading gains Fortescue surges nearly 5pc as iron ore prices climb Star Entertainment plunges over 40pc after trading halt lifted   The ASX rose modestly by 0.1% on Friday, buoyed by a surge in min...

Stockhead IVX 2 months ago
Top 10 at 11: Medtech, cancer drugs and fintech are this morning’s big winners

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 2 months ago
Updates from the Biopharmaceutical Sector: Paradigm Biopharmaceuticals, Actinogen Medical, and Invion

Recent updates highlight significant strides in the biopharmaceutical sector. Paradigm Biopharmaceuticals Ltd has received FDA feedback on its Phase III osteoarthritis study. Actinogen Medical Ltd has secured funding for its Alzheimer’s tri...

Kalkine Media IVX 3 months ago
Closing Bell: ASX choppy as traders sit it out; BPM soars on Mt Gibson gold find

  ASX slips after hitting new high ahead of Fed decision Iron ore prices expected to drop below US$80 by 2025 Harvey Norman faces class action lawsuit over warranties   The ASX was a bit of a mixed bag today, hitting a new high before pu...

Stockhead IVX 3 months ago
Invion’s INV043 candidate demonstrates positive results in Phase II prostate cancer trial

Life sciences group Invion (ASX: IVX) has announced that its photodynamic technology (PDT) partner RMW Cho Group has completed a Phase II prostate cancer trial using its active pharmaceutical ingredient and lead cancer candidate INV043. The...

SmallCaps IVX 3 months ago
Health Check: Paradigm receives FDA guidance on proposed trial for dodgy knees

Health Check (briefly called Alive and Kicking before we grew tired of the Simple Minds tune running through our noggins) is renowned biotech journo Tim Boreham’s NEW daily wrap covering morning movers and shakers of note in the ASX Healthc...

Stockhead IVX 3 months ago
Alive and Kicking: Prescient Therapeutics chief passes CEO baton after eight years in the job

Alive and Kicking is renowned biotech journo Tim Boreham’s new daily wrap covering morning movers and shakers of note in the ASX Healthcare sector, Monday through Thursday.   Prescient Therapeutics chief Steve Yatomi-Clarke resigns to hea...

Stockhead IVX 3 months ago
Closing Bell: ASX falls but lithium stocks rally big on China news; MinRes also jumps 17pc

  ASX falls on Wednesday with banks dragging down market Lithium stocks surge on CATL suspension reports; MinRes hits new high Energy stocks struggle as Brent drops below US$70   The ASX was on the back foot on Wednesday, down by 0.3%  w...

Stockhead IVX 3 months ago
Top 10 at 11: Titanium sands, defence training and project progress is the news today

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 3 months ago
Closing Bell: ASX lifts as CBA, Mac Bank hit record highs; Aruma Resources doubles

ASX closes higher as CBA and Macquarie touch records Lotus Resources finds significant uranium; gold stocks await US CPI data UBS favours ASX banks over miners   The ASX bounced back by 0.4% on Tuesday after  yesterday’s slump, with the...

Stockhead IVX 3 months ago
Closing Bell: ASX tracks global selloff; Yancoal and GYG amongst new ASX200 entrants

  ASX slips  as US jobs data fuels Wall Street panic Westpac gets a new CEO Newcomers into the ASX200 index include Guzman u Gomez   The ASX stumbled by 0.3% on Monday after the US jobs report fell short on Friday night, causing Wall Str...

Stockhead IVX 3 months ago
Top 10 at 11: Air traffic control training is what’s in the news this morning

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 3 months ago
Closing Bell: ASX steady as coal play Coronado sinks 16pc; NextDC rides on data centre boom

ASX up on Thursday, tech stocks rise boosted by NextDC Wodside Energy drops due to downgrade and oil price fall Iron Ore and coal slide, and Coronado sinks on production and cost issues   After a rough session on Wednesday, the ASX saw a...

Stockhead IVX 3 months ago
Top 10 at 11: Antimony assays, bad weather and local lockout are today’s top stories

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 3 months ago
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

Stockhead IVX 3 months ago
Closing Bell: Star Casino ruled unfit to reclaim licence; Cassius jumps 40pc as AustChina exits lithium deal

ASX 200 up on Friday boosted by strong US GDP and Wall Street gains Star Entertainment gets scathing remarks from regulator Downer EDI and TPG Telecom among the stocks to surge today   The ASX closed 0.58% higher on Friday as investors di...

Stockhead IVX 3 months ago
Closing Bell: ASX slides as Qantas’ profit takes big dip; MC Mining triples on Chinese coal deal

The ASX lagged on Thursday after Nvidia’s disappointing Q3 guidance Mineral Resources fell 8pc off a major profit drop Qantas saw a 28pc drop in profit but saw modest share price gains   The ASX was sluggish on Thursday, down 0.33%, follo...

Stockhead IVX 3 months ago
Closing Bell: CPI reading shifts rate cut outlook; Tabcorp plunges 15pc while Felix Gold soars

Aussie stocks dropped despite Wall Street edging up ahead of Nvidia’s report Inflation eased to 3.5pc, impacting rate cut predictions Fortescue and Flight Centre reported gains; Woolworths and Tabcorp faced losses   Aussie stocks dropped...

Stockhead IVX 3 months ago
Closing Bell: Uranium stocks surge as crunch looms; Actinogen, Kalina lead ASX gains

Aussie shares rose on Fed rate cut hopes Kelsian plunged, while Kalina, Actinogen and Kogan surged Uranium stocks gained on Kazatomprom’s production guidance cut   Aussie shares have kicked off the week strongly, buoyed by US Fed Reserve...

Stockhead IVX 3 months ago
Top 10 at 11: Gas powered AI, happy pills, antimony and gold are today’s hot news

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 3 months ago
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators

ASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price rebound, energy stocks fell   The ASX 200 ended its 10-day winning streak, dipping by 0.04% after a weak session on Wall Street overnight....

Stockhead IVX 4 months ago
Closing Bell: Origin, Cochlear dive on earnings; RBA rate cut looks less likely after jobs report

ASX up as earnings season rolls on; Origin down 10pc, Telstra up 3pc Australia’s unemployment rate edged up to 4.2pc from 4.1pc Iron ore futures dropped below US$94 per ton   The ASX edged slightly higher by 0.1% on Thursday, boosted by a...

Stockhead IVX 4 months ago
Closing Bell: Markets still bumpy as ASX drops again; Qantas admits board made mistakes

The ASX dropped, dragged down by Real Estate and Mining stocks Qantas cuts former CEO’s compensation by $9.3m Fears of a US recession are growing, with the Sahm Rule signalling potential trouble   A selloff in Real Estate and Mining stock...

Stockhead IVX 4 months ago
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

Stockhead IVX 4 months ago
Top 10 at 11: Manganese and a successul cap raise re driving things forward this morning

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead IVX 4 months ago